XCUR

Exicure, Inc.

0.37 USD
+0.03 (+10.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Exicure, Inc. stock is down -29.04% since 30 days ago. The next earnings date is Jul 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 June’s closed higher than May.

About Exicure, Inc.

Exicure, Inc. develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders.